W. Kim

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.

E. Small, D. Rathkopf, D. Olmos, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer

H. Pyo, Y. Lim, D. Kim, 2012, Strahlentherapie und Onkologie.

Long-term outcome of whole pelvis radiotherapy and stereotactic body radiotherapy boost for intermediate and high risk prostate cancer

W. C. Kim, H. Kim, J. S. Lee, 2022 .

Radiation treatment in patients with recurrent Kimura's disease.

S. Kim, W. C. Kim, H. Suh, 1997, International journal of radiation oncology, biology, physics.

High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.

C. Suh, W. C. Kim, G. Kim, 2001, Japanese journal of clinical oncology.

Early toxicity of moderate hypofractionated volumetric modulated Arc radiotherapy for localized prostate cancer

J. Lee, H. Kim, W. C. Kim, 2021 .

Moderate hypofractionated volumetric modulated Arc therapy with daily image guidance for patients with localized prostate cancer

J. Lee, H. Kim, W. C. Kim, 2022 .

Moderate hypofractionated volumetric modulated Arc therapy with daily image guidance for patients with localized prostate cancer

J. Lee, H. Kim, W. C. Kim, 2021 .

Moderate hypofractionated volumetric modulated Arc therapy with daily image guidance for patients with localized prostate cancer

J. Lee, H. Kim, W. C. Kim, 2021 .

Moderate hypofractionated volumetric modulated Arc therapy with daily image guidance for patients with localized prostate cancer

J. Lee, H. Kim, W. C. Kim, 2021 .